The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor

SIMPLE SUMMARY: Melanoma is an aggressive cancer type with a high tendency to spread to distant body sites, including bones. Despite the availability of effective therapies, many patients still do not fully benefit from treatment. The aim of our study was to evaluate the therapeutic potential of inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Atzori, Maria Grazia, Ceci, Claudia, Ruffini, Federica, Scimeca, Manuel, Cicconi, Rosella, Mattei, Maurizio, Lacal, Pedro Miguel, Graziani, Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688925/
https://www.ncbi.nlm.nih.gov/pubmed/36428669
http://dx.doi.org/10.3390/cancers14225578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688925/
https://www.ncbi.nlm.nih.gov/pubmed/36428669
http://dx.doi.org/10.3390/cancers14225578

Ejemplares similares